Dasan Famotidine Tablet 20 mg (Famotidine)

Adult dose

1. For gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding, gastroesophageal reflux disease, Zollinger-Ellison syndrome: Administer Famotidine 20 mg orally twice a day (after breakfast, after dinner, or at bedtime) or 40 mg orally once daily (at bedtime). For upper gastrointestinal bleeding, initiate treatment with an injection and switch to oral administration once it becomes possible. 2. For improvement of gastric mucosal lesions (acute gastritis

This medication should not be used by individuals who are allergic to specific ingredients or have previously taken similar medications and experienced hypersensitivity reactions. Additionally, as it contains lactose, individuals with lactose intolerance or specific sugar absorption disorders should not take it. Caution should be exercised in individuals with a history of allergies, kidney or liver function issues, heart disease, and the elderly should particularly take care when using it. Rarely, this medication can cause serious side effects, so if any unusual symptoms such as difficulty breathing, rash, severe muscle pain, or altered consciousness occur, use should be stopped immediately and medical consultation sought. It is important to have regular blood tests or liver and kidney function tests to monitor any unusual signs. The tablet should be swallowed with water as it dissolves in the mouth but is not absorbed through the mucosa, and if it is ineffective, other treatment options should be considered. Taking certain antifungal or anticancer drugs may reduce the effectiveness of this medication, so it is essential to inform your physician if you are taking other medicines. Elderly individuals may require dose adjustments or extended intervals between doses due to potential prolonged effects of the drug in their system. Women who are pregnant or may become pregnant should only use this medication after carefully weighing the benefits and risks, and it is advisable for breastfeeding women to stop breastfeeding while on this medication. The safety for children has not been sufficiently established, so its use is not recommended. Finally, as this medication can mask symptoms of gastric cancer, it should be used only after confirming the absence of gastric cancer.

Serious side effects

Shock, hypersensitivity (anaphylaxis, difficulty breathing, generalized flushing, angioedema, urticaria), pancytopenia, agranulocytosis, aplastic anemia, hemolytic anemia, thrombocytopenia, Stevens-Johnson syndrome, Lyell syndrome, liver dysfunction, jaundice, rhabdomyolysis, QT prolongation, ventricular tachycardia, ventricular fibrillation, altered consciousness, seizures, interstitial nephritis, acute kidney failure, interstitial pneumonia, failure to contract

Mild side effects

• Rash
• urticaria
• flushing (erythema)
• facial edema
• leukopenia
• eosinophilia
• constipation
• diarrhea
• soft stools
• dry mouth

Store this medication in a tightly sealed container to protect it from air, and keep it at a temperature between 1 and 30 degrees Celsius (room temperature). Proper storage helps maintain the efficacy of the medication over time.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle